Gemcitabine hydrochloride
Product description
Name | Gemcitabine hydrochloride |
Synonyms | 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-pyrimidin-2-one hydrochloride |
Molecular Formula | C9H11F2N3O4.HCl |
Molecular Weight | 299.66 |
CAS Registry Number | 122111-03-9 |
White crystalline powder, odorless
Cytosine≤0.1%
α-anomer≤0.1%
Other individual impurity≤0.2%
Residue on ignition≤0.1%
Heavy metals≤10ppm
Assay:97.5~101.5%
Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic.
Suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Recommended products